Search Results
You are looking at 1 - 1 of 1 items for
- Author: Sohana Siyar x
- Refine by access: All content x
Search for other papers by Jun Huang in
Google Scholar
PubMed
Search for other papers by Rita Sharma in
Google Scholar
PubMed
Search for other papers by Sohana Siyar in
Google Scholar
PubMed
The Diabetes Institute, Ohio University, Athens, Ohio, USA
Search for other papers by Vishva Sharma in
Google Scholar
PubMed
The Diabetes Institute, Ohio University, Athens, Ohio, USA
Search for other papers by Vishwajeet Puri in
Google Scholar
PubMed
The Diabetes Institute, Ohio University, Athens, Ohio, USA
Search for other papers by Kevin Y Lee in
Google Scholar
PubMed
Studies in humans and mice have determined that distinct subpopulations of adipocytes reside even within individual adipose tissue depots. Previously, our lab defined three white adipocyte subpopulations with stable and unique gene expression profiles, which were termed type 1, 2, and 3 adipocytes, respectively. Our previous studies demonstrated that type 2 adipocytes were highly responsive to the inflammatory cytokine, tumor necrosis factor alpha (TNFα). This study extends these findings to investigate the role of type 2 adipocytes in obesity. We found that treatment with TNFα increased lipolysis specifically in type 2 adipocytes, at least in part, through the reduction of fat-specific protein 27 (FSP27) expression. To assess the physiological role of lipolysis from this adipocyte subpopulation, a type2Ad-hFSP27tg mouse model was generated by overexpressing human FSP27 specifically in type 2 adipocytes. Glucose and insulin tolerance test analysis showed that male type2Ad-hFSP27tg mice on 60% high-fat diet exhibited improved glucose tolerance and insulin sensitivity, with no change in body weight compared to controls. These metabolic changes may, at least in part, be explained by the reduced lipolysis rate in the visceral fat of type2Ad-hFSP27tg mice. Although FSP27 overexpression in primary type 2 adipocytes was sufficient to acutely reduce TNFα-induced apoptosis in vitro, it failed to reduce macrophage infiltration in obesity in vivo. Taken together, these results strongly suggest that type 2 adipocytes contribute to the regulation of lipolysis and could serve as a potential therapeutic target for obesity-associated insulin resistance.
